D360 Scientific Informatics Discovery Platform: User Stories
Transcript: I've joined companies both blueprint medicines and score therapeutics is one of the first…
Certara2024 年 2 月 8 日
Upping the Ante for Predicting the Success of Alzheimer Disease Treatments
By Hugo Geerts, PhD, Piet van der Graaf, PharmD, PhD Over the past 20 years,…
Jim Gallagher2024 年 2 月 8 日
Drug Development’s New Model: Biosimulation from Discovery to Label Expansion
Key Highlights: How predictive technologies reshape drug development, mitigating project risks, navigating novel biomarkers, predicting…
Danielle Pillsbury2024 年 2 月 2 日
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader…
Danielle Pillsbury2024 年 2 月 1 日
Navigating Market Access for Healthcare Products: The Power of the Global Value Dossier
This blog defines the global value dossiers and explains how BaseCase can support creating interactive…
Jim Gallagher2024 年 1 月 24 日
Navigating the “Patent Cliff”: Omni-channel Strategies for Loss of Exclusivity and Established Products
Join us to understand the dynamics of the pharmaceutical market and learn how to maintain…
Danielle Pillsbury2024 年 1 月 24 日
Understanding the Role of Your Discovery Asset’s Target Product Profile
If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly…
Jim Gallagher2024 年 1 月 19 日
